MAXIMUS, Inc. (NYSE:MMS) Vice Chairman Richard A. Montoni sold 12,000 shares of the firm’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $78.04, for a total value of $936,480.00. Following the completion of the sale, the insider now directly owns 337,874 shares in the company, valued at $26,367,686.96. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.
Shares of NYSE:MMS traded up $0.89 during midday trading on Thursday, hitting $80.66. The company’s stock had a trading volume of 374,188 shares, compared to its average volume of 306,714. The stock has a market capitalization of $5.13 billion, a price-to-earnings ratio of 23.72, a PEG ratio of 2.11 and a beta of 0.88. The stock’s 50 day simple moving average is $75.90 and its 200 day simple moving average is $73.22. MAXIMUS, Inc. has a fifty-two week low of $60.00 and a fifty-two week high of $81.03.
MAXIMUS (NYSE:MMS) last issued its quarterly earnings results on Thursday, August 8th. The health services provider reported $0.97 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.93 by $0.04. The company had revenue of $730.70 million for the quarter, compared to the consensus estimate of $754.81 million. MAXIMUS had a return on equity of 20.72% and a net margin of 8.44%. The firm’s revenue was up 22.2% compared to the same quarter last year. During the same period last year, the business posted $0.91 earnings per share. Analysts forecast that MAXIMUS, Inc. will post 3.73 EPS for the current fiscal year.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in MMS. Strs Ohio lifted its stake in shares of MAXIMUS by 7.5% in the second quarter. Strs Ohio now owns 10,000 shares of the health services provider’s stock valued at $725,000 after buying an additional 700 shares during the period. Stratos Wealth Partners LTD. bought a new stake in shares of MAXIMUS in the first quarter valued at about $292,000. Geode Capital Management LLC lifted its stake in shares of MAXIMUS by 11.9% in the fourth quarter. Geode Capital Management LLC now owns 976,831 shares of the health services provider’s stock valued at $63,581,000 after buying an additional 103,638 shares during the period. WINTON GROUP Ltd bought a new stake in shares of MAXIMUS in the second quarter valued at about $1,008,000. Finally, Mason Street Advisors LLC lifted its stake in shares of MAXIMUS by 1.0% in the first quarter. Mason Street Advisors LLC now owns 33,926 shares of the health services provider’s stock valued at $2,408,000 after buying an additional 333 shares during the period. Institutional investors and hedge funds own 94.88% of the company’s stock.
Several equities research analysts have recently issued reports on MMS shares. Zacks Investment Research raised MAXIMUS from a “hold” rating to a “buy” rating and set a $75.00 price target on the stock in a research report on Monday, May 27th. Canaccord Genuity raised their price target on MAXIMUS from $72.00 to $77.00 and gave the company a “hold” rating in a research report on Tuesday, August 13th. Wells Fargo & Co reaffirmed a “market perform” rating and issued a $83.00 price target on shares of MAXIMUS in a research report on Friday, August 9th. Finally, ValuEngine downgraded MAXIMUS from a “buy” rating to a “hold” rating in a research report on Friday, June 28th.
MAXIMUS, Inc provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews.
Featured Story: What is a support level?
Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.